On Friday, Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) opened lower -0.46% from the last session, before settling in for the closing price of $26.15. Price fluctuations for ARWR have ranged from $17.05 to $39.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -2.87% over the last five years. Company’s average yearly earnings per share was noted 31.99% at the time writing. With a float of $113.68 million, this company’s outstanding shares have now reached $124.38 million.
The firm has a total of 609 workers. Let’s measure their productivity. In terms of profitability, gross margin is -282.15%, operating margin of -16927.06%, and the pretax margin is -17247.54%.
Arrowhead Pharmaceuticals Inc (ARWR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arrowhead Pharmaceuticals Inc is 8.64%, while institutional ownership is 76.53%. The most recent insider transaction that took place on Jul 02 ’24, was worth 237,480. In this transaction Chief Commercial Officer of this company sold 9,394 shares at a rate of $25.28, taking the stock ownership to the 127,107 shares. Before that another transaction happened on May 02 ’24, when Company’s Director sold 1,799 for $23.31, making the entire transaction worth $41,935. This insider now owns 30,205 shares in total.
Arrowhead Pharmaceuticals Inc (ARWR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 31.99% per share during the next fiscal year.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Trading Performance Indicators
Check out the current performance indicators for Arrowhead Pharmaceuticals Inc (ARWR). In the past quarter, the stock posted a quick ratio of 6.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 908.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.00, a number that is poised to hit -0.73 in the next quarter and is forecasted to reach -3.35 in one year’s time.
Technical Analysis of Arrowhead Pharmaceuticals Inc (ARWR)
Analysing the last 5-days average volume posted by the [Arrowhead Pharmaceuticals Inc, ARWR], we can find that recorded value of 3.84 million was better than the volume posted last year of 1.25 million. As of the previous 9 days, the stock’s Stochastic %D was 91.66%. Additionally, its Average True Range was 1.55.
During the past 100 days, Arrowhead Pharmaceuticals Inc’s (ARWR) raw stochastic average was set at 67.22%, which indicates a significant decrease from 85.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.28% in the past 14 days, which was higher than the 62.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.05, while its 200-day Moving Average is $24.41. Now, the first resistance to watch is $27.02. This is followed by the second major resistance level at $28.02. The third major resistance level sits at $28.69. If the price goes on to break the first support level at $25.35, it is likely to go to the next support level at $24.68. Now, if the price goes above the second support level, the third support stands at $23.68.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Key Stats
There are currently 124,434K shares outstanding in the company with a market cap of 3.22 billion. Presently, the company’s annual sales total 240,740 K according to its annual income of -205,280 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -125,300 K.